Clinical Qualification of Subcutaneous Injection Devices for Monoclonal Antibodies.
Saved in:
| Title: | Clinical Qualification of Subcutaneous Injection Devices for Monoclonal Antibodies. |
|---|---|
| Authors: | Bittner B; F. Hoffmann-La Roche Ltd., Global Pharma Strategy-Product Optimization, Grenzacherstr. 124, 4070, Basel, Switzerland. beate.bittner@roche.com., Munoz J; F. Hoffmann-La Roche Ltd., Global Pharma Strategy-Product Optimization, Grenzacherstr. 124, 4070, Basel, Switzerland., Frank S; F. Hoffmann-La Roche Ltd., Product Development-Regulatory Program Management, Basel, Switzerland., Dolton M; F. Genentech, Research and Early Development-Clinical Pharmacology, South San Francisco, CA, USA., Ravanello R; F. Hoffmann-La Roche Ltd, Pharma Technical-Device Development, South San Francisco, CA, USA., Dembowski M; F. Hoffmann-La Roche Ltd., Pharma Technical-Biologics, Basel, Switzerland., Clement A; F. Hoffmann-La Roche Ltd., Product Development-Regulatory Program Management, Basel, Switzerland., Richter WF; Lörrach, Germany. |
| Source: | BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy [BioDrugs] 2026 Jan; Vol. 40 (1), pp. 5-21. Date of Electronic Publication: 2025 Nov 17. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9705305 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-190X (Electronic) Linking ISSN: 11738804 NLM ISO Abbreviation: BioDrugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41247399 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Clinical Qualification of Subcutaneous Injection Devices for Monoclonal Antibodies. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Bittner+B%22">Bittner B</searchLink>; F. Hoffmann-La Roche Ltd., Global Pharma Strategy-Product Optimization, Grenzacherstr. 124, 4070, Basel, Switzerland. beate.bittner@roche.com.<br /><searchLink fieldCode="AU" term="%22Munoz+J%22">Munoz J</searchLink>; F. Hoffmann-La Roche Ltd., Global Pharma Strategy-Product Optimization, Grenzacherstr. 124, 4070, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Frank+S%22">Frank S</searchLink>; F. Hoffmann-La Roche Ltd., Product Development-Regulatory Program Management, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Dolton+M%22">Dolton M</searchLink>; F. Genentech, Research and Early Development-Clinical Pharmacology, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ravanello+R%22">Ravanello R</searchLink>; F. Hoffmann-La Roche Ltd, Pharma Technical-Device Development, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Dembowski+M%22">Dembowski M</searchLink>; F. Hoffmann-La Roche Ltd., Pharma Technical-Biologics, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Clement+A%22">Clement A</searchLink>; F. Hoffmann-La Roche Ltd., Product Development-Regulatory Program Management, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Richter+WF%22">Richter WF</searchLink>; Lörrach, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229705305%22">BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy</searchLink> [BioDrugs] 2026 Jan; Vol. 40 (1), pp. 5-21. <i>Date of Electronic Publication: </i>2025 Nov 17. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9705305 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-190X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211738804%22">11738804 </searchLink><i>NLM ISO Abbreviation: </i>BioDrugs <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41247399 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s40259-025-00755-9 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 5 Titles: – TitleFull: Clinical Qualification of Subcutaneous Injection Devices for Monoclonal Antibodies. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bittner B – PersonEntity: Name: NameFull: Munoz J – PersonEntity: Name: NameFull: Frank S – PersonEntity: Name: NameFull: Dolton M – PersonEntity: Name: NameFull: Ravanello R – PersonEntity: Name: NameFull: Dembowski M – PersonEntity: Name: NameFull: Clement A – PersonEntity: Name: NameFull: Richter WF IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2026 Jan Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1179-190X Numbering: – Type: volume Value: 40 – Type: issue Value: 1 Titles: – TitleFull: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy Type: main |
| ResultId | 1 |